|
GNG5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.583800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.814400E-02 |
| Normal-vs-Stage2 |
7.646200E-02 |
| Normal-vs-Stage3 |
4.950200E-02 |
| Normal-vs-Stage4 |
6.524200E-02 |
| Stage1-vs-Stage2 |
9.592600E-01 |
| Stage1-vs-Stage3 |
6.170400E-01 |
| Stage1-vs-Stage4 |
1.194770E-01 |
| Stage2-vs-Stage3 |
6.531600E-01 |
| Stage2-vs-Stage4 |
1.200780E-01 |
| Stage3-vs-Stage4 |
1.468230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.020500E-03 |
| Normal-vs-AfricanAmerican |
1.020220E-01 |
| Normal-vs-Asian |
3.493900E-02 |
| Caucasian-vs-AfricanAmerican |
3.546000E-01 |
| Caucasian-vs-Asian |
4.754000E-01 |
| AfricanAmerican-vs-Asian |
2.221200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.171650E-02 |
| Normal-vs-Female |
9.579000E-03 |
| Male-vs-Female |
6.697000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.810300E-02 |
| Normal-vs-Extreme_Weight |
1.178470E-02 |
| Normal-vs-Obese |
9.668000E-02 |
| Normal-vs-Extreme_Obese |
6.598000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.178800E-01 |
| Normal_Weight-vs-Obese |
3.028400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.881600E-01 |
| Extreme_Weight-vs-Obese |
3.120200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.611000E-01 |
| Obese-vs-Extreme_Obese |
5.443600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.822900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.296500E-03 |
| Normal-vs-Age(61-80Yrs) |
5.916300E-02 |
| Normal-vs-Age(81-100Yrs) |
5.797400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.668000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.345800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.604000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.027000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.057970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.474600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.218400E-03 |
| Normal-VS-Type2 PRCC |
2.236400E-01 |
| Normal-VS-KIRP CIMP |
1.193570E-02 |
| Normal-VS-Unclassified PRCC |
2.696000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.651600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.753200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.352400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.938600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.099600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.493400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.806500E-02 |
| Normal-vs-N1 |
6.301600E-02 |
| Normal-vs-N2 |
2.368200E-01 |
| N0-vs-N1 |
1.827790E-01 |
| N0-vs-N2 |
3.166400E-01 |
| N1-vs-N2 |
6.518200E-01 |
|
|
